...
首页> 外文期刊>Open Journal of Nephrology >Acute Kidney Injury Caused by Darunavir in a Patient with COVID-19: A Case Report
【24h】

Acute Kidney Injury Caused by Darunavir in a Patient with COVID-19: A Case Report

机译:Covid-19患者达伦韦尔引起的急性肾损伤:案例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: A highly contagious virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic globally. HIV medications were one of the suggested treatments for Coronavirus disease 2019 (COVID-19). Here, we report an unusual adverse drug reaction with darunavir in a SARS-CoV-2-infected patient. Case Presentation: This is a case presentation of a 53-year-old male with no past medical history who was diagnosed with COVID-19. One week after initiating treatment, the patient developed acute kidney injury, and his serum creatinine increased significantly. Conclusion: As there was no clear justification for renal impairment such as a prerenal or postrenal cause, acute kidney injury, possibly crystal-induced nephropathy, was considered an adverse drug reaction from darunavir.
机译:背景:被称为严重急性呼吸综合征Coronavirus 2(SARS-COV-2)的高度传染性病毒一直是大流行。艾滋病毒药物是2019年冠状病毒疾病的建议治疗之一(Covid-19)。在这里,我们在SARS-COV-2感染患者中报告了与Darunavir的不寻常的不良药物反应。案例介绍:这是一个53岁男性的案例介绍,没有过去的病史,他们被诊断出患有Covid-19。在启动治疗后一周,患者发育急性肾损伤,他的血清肌酐显着增加。结论:由于肾病或病因等肾脏损伤没有明确的理由,急性肾损伤,可能是晶体诱导的肾病,被认为是达尔努瓦尔的不良药物反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号